First-line tandem high-dose chemotherapy and autologous stem cell transplantation versus single high-dose chemotherapy and autologous stem cell transplantation in multiple myeloma, a systematic review of controlled studies
Options
BORIS DOI
Publisher DOI
PubMed ID
23076906
Description
Several clinical studies have compared single with tandem (also called double) autologous stem cell transplantation (ASCT) as first-line treatment in patients with symptomatic multiple myeloma (MM), one of the leading indications for ASCT worldwide.
Date of Publication
2012
Publication Type
Article
Subject(s)
Language(s)
en
Contributor(s)
Naumann-Winter, Frauke | |
Greb, Alexander | |
Borchmann, Peter | |
Engert, Andreas | |
Schnell, Roland |
Additional Credits
Series
Cochrane database of systematic reviews
Publisher
WileyInterscience
ISSN
1469-493X
Access(Rights)
open.access